Product NDC: | 0206-8855 |
Proprietary Name: | Zosyn |
Non Proprietary Name: | piperacillin sodium and tazobactam sodium |
Active Ingredient(s): | 4; .5 g/20mL; g/20mL & nbsp; piperacillin sodium and tazobactam sodium |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0206-8855 |
Labeler Name: | Pfizer Pharmaceuticals LLC, Pfizer Pharmaceutical LLC - Piperacillin |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050684 |
Marketing Category: | NDA |
Start Marketing Date: | 19931101 |
Package NDC: | 0206-8855-16 |
Package Description: | 10 VIAL, SINGLE-USE in 1 CARTON (0206-8855-16) > 20 mL in 1 VIAL, SINGLE-USE (0206-8855-08) |
NDC Code | 0206-8855-16 |
Proprietary Name | Zosyn |
Package Description | 10 VIAL, SINGLE-USE in 1 CARTON (0206-8855-16) > 20 mL in 1 VIAL, SINGLE-USE (0206-8855-08) |
Product NDC | 0206-8855 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | piperacillin sodium and tazobactam sodium |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19931101 |
Marketing Category Name | NDA |
Labeler Name | Pfizer Pharmaceuticals LLC, Pfizer Pharmaceutical LLC - Piperacillin |
Substance Name | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
Strength Number | 4; .5 |
Strength Unit | g/20mL; g/20mL |
Pharmaceutical Classes | beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA] |